Cavalier King Charles Spaniel

Cavalier neonates are entirely dependent: eyes and ear canals are sealed, thermoregulation is absent, and locomotion is limited to crawling toward the dam. The breeder's vigilance in this window is the single greatest determinant of puppy survival.

• Whelping weight check: weigh each puppy at birth and every 24 hours. Healthy puppies gain roughly 5–10 % of birth weight per day; any puppy losing weight or failing to regain birth weight within 24 hours needs supplemental feeding. • Warmth: ambient temperature in the whelping box should be 29–32 °C (84–90 °F) for the first week, reducing to 26 °C in week two. Cavalier puppies cannot shiver and will die from hypothermia within hours if chilled. • Nursing: ensure each puppy nurses within two hours of birth to receive colostrum (passive immune transfer closes at ~12 hours post-partum). Check that the dam has sufficient milk and that smaller littermates are not displaced. • Fading-puppy vigilance: persistent crying, cold skin, bloated abdomen, or failure to nurse are emergency signs — contact the vet or an experienced breeder immediately. • No interventions: no vaccinations, no worming, no grooming needed at this stage. The dam handles all stimulation, elimination, and warming.

Eyes open between days 10 and 14; ear canals open around day 14–17. Puppies begin to stand, walk unsteadily, and interact with littermates. The dam begins weaning, and the puppies' gut flora starts to diversify. This is the beginning of the sensitive socialisation window.

• Eyes and ears: confirm all puppies open eyes by day 16; persistent closure or discharge warrants veterinary assessment for ocular abnormality. • First teeth: deciduous incisors begin to erupt around week 3–4. • Weaning preparation: begin introducing a thin gruel (high-quality puppy-specific food mashed with warm water) by days 21–28, offered several times daily alongside continued nursing. • Early neurological stimulation (ENS): brief daily handling exercises (tactile stimulation, mild cold stimulus, head-up/head-down positioning, supine cradle) during days 3–16 have been shown in military-breeding research to improve stress tolerance and trainability — optional but evidence-supported. • Begin gentle, calm human contact daily: pick up, hold, speak softly. The breeder's handling at this stage shapes the puppy's lifetime relationship with people. • First worming dose: administer a broad-spectrum anthelmintic (pyrantel pamoate or fenbendazole) at 2 weeks, per ESCCAP and WSAVA guidelines, to address transplacentally and lactogenically acquired roundworm (Toxocara canis).

The primary socialisation window (approximately 3–12 weeks) is the most important developmental period in a dog's life. Neural plasticity is at its peak: positive exposure to sounds, surfaces, people, children, other animals, and novel environments during this window produces a confident, resilient adult. Deprivation during this window cannot be fully compensated for later. For the Cavalier — a breed whose temperament is its defining asset — this period is foundational.

Why this window matters more for Cavaliers: The Cavalier's gentle, people-oriented temperament is partly heritable and partly shaped by early experience. A puppy deprived of human contact before 8 weeks, or raised in an isolated pen without novel stimuli, will often be fearful and difficult to rehabilitate. This is a primary red flag when evaluating breeders.

• Weaning: complete by 7–8 weeks. Puppies should be eating puppy-specific food (small-breed or toy-breed formula) four times daily. Cavalier puppies have small stomachs and low glycogen reserves — do not allow extended fasting. • Socialisation targets (breeder's responsibility, weeks 3–8): expose to gentle children, men with beards, umbrellas, car rides, crates, different floor surfaces, grooming tools, nail clippers (used gently), and mild startle sounds. Quality counts — no flooding, no forced exposure. • Socialisation targets (new owner, weeks 8–12): continue broadening exposure — markets, traffic, bicycles, other vaccinated dogs. Every positive novel experience in this window is a deposit in a lifetime confidence account. • First veterinary visit (as soon as possible after 8 weeks): physical exam including heart auscultation (congenital cardiac defects occur in the breed), patellar palpation, bite assessment, ophthalmic check. Establish the dog's health baseline. • Vaccination — core: first puppy vaccination typically at 6–8 weeks. Core vaccines per WSAVA guidelines: modified-live canine distemper virus (CDV), canine adenovirus type 2 (CAV-2, which cross-protects against CAV-1/infectious hepatitis), and canine parvovirus type 2 (CPV-2) — given as a combination MLV (e.g. DHPPi). • Vaccination — non-core for tropical climates: leptospirosis (L2 or L4 bivalent/tetravalent) is considered core in hot, humid climates given the documented reservoir risk from urban rodents and flooding events — begin alongside the DHPPi series. • Heartworm prophylaxis (commence at 8 weeks): Dirofilaria immitis is transmitted year-round in tropical climates. Begin monthly macrocyclic lactone prophylaxis (milbemycin oxime, ivermectin, or moxidectin-based product) from 8 weeks of age per American Heartworm Society guidance. Do not wait. • Parasite prevention: monthly broad-spectrum parasiticide covering fleas, ticks, and intestinal worms. In tropical and subtropical climates, tick-borne diseases (Ehrlichia, Babesia, Hepatozoon) represent a genuine risk; a product with acaricidal activity (isoxazoline class or pyrethroid collar) is appropriate from first acquisition. • Repeat worming: at 4 and 6 weeks of age, then monthly to 6 months (ESCCAP guideline). • Crate training and alone-time: begin from week 8. The Cavalier is prone to separation anxiety; teaching comfort with short absences early prevents a significant welfare problem later. • Puppy classes: enrol from 7–8 weeks old, provided the venue requires vaccination records and uses force-free methods. The AVMA and the AVSAB state that the socialisation benefit of puppy classes outweighs the residual disease risk in a vaccinated puppy — the single most evidence-supported investment in your Cavalier's behaviour.

Rapid physical growth, teething, and the completion of the puppy vaccination series dominate this stage. Cavaliers are biddable and respond well to short, reward-based training sessions; the cognitive foundations laid here persist for life.

• Vaccination completion: second and third puppy vaccinations at 3-week intervals, with the final dose no earlier than 16 weeks to override waning maternal antibody. A titre test 2–4 weeks after the final dose can confirm seroconversion if there is any doubt. • Leptospirosis: complete the two-dose primary course (3–4 weeks apart) and note the annual booster requirement — leptospiral immunity wanes faster than core vaccine immunity. • Kennel cough (Bordetella bronchiseptica ± parainfluenza — non-core): recommended if the dog will attend kennels, dog parks, grooming salons, or training classes. Intra-nasal or oral vaccines provide faster mucosal immunity than injectable. • Teething: deciduous teeth shed between 3 and 6 months as the 42 permanent teeth erupt. Expect increased chewing. Check that all deciduous teeth are shed — retained deciduous canines are common in small breeds and require extraction to prevent malocclusion and periodontal disease. • First dental hygiene: introduce tooth brushing daily from as early as possible. Use a pet toothpaste with enzymatic activity (human toothpaste is toxic). The Cavalier's narrow jaw and crowded dentition make periodontal disease a significant morbidity by middle age if brushing is neglected. • Feeding: four meals daily to 3 months, then three meals to 6 months. Use a small-breed puppy food that meets AAFCO/FEDIAF nutritional adequacy standards for growth. Weigh weekly; adjust to keep a visible waist and ribs felt easily under a light fat cover. Obesity accelerates MVD progression. • Training milestones: sit, down, stay, come, leave it, loose-lead walking should be substantially in place by 6 months. Cavaliers are soft-natured — harsh correction is never appropriate and is particularly counterproductive in this breed. • Neutering discussion: discuss timing with your vet at the 4-month visit. The BSAVA and many UK vets recommend waiting until after puberty (9–12 months in toy breeds) based on orthopaedic and behavioural evidence. For a small-breed dog such as the Cavalier, the traditional 6-month recommendation is being revised toward 9–12 months in many protocols — discuss pros, cons, surgical method, and alternatives openly. • Microchipping: mandatory in tropical regions (local animal welfare legislation) before or at the time of licensing. Confirm implantation and registration in the National Pet Registration database. • Dog licensing: confirm requirements with your local authority. Microchipping and annual or lifetime licensing is required in most jurisdictions.

Hormonal change and adolescent brain remodelling produce the familiar "teenager" phase: selective hearing, impulse-control regressions, and increased environmental curiosity. This is the most common period for owners to seek behaviour help. Staying consistent with training and managing frustration carries most dogs through it intact.

• First annual booster (at 12 months): administer per your vet's protocol. Per WSAVA guidelines, core vaccines (CDV, CPV-2, CAV) given as a complete puppy series can be triennialized after the 12-month booster. Leptospirosis, kennel cough, and rabies (where required) remain annual. • Rabies vaccine: requirements vary by country — confirm with your local veterinary authority. Mandatory for international travel in most jurisdictions; consult the relevant authority on international travel certificate requirements at least 3 months before any travel. • Heartworm and parasite prevention: continue monthly, without gaps. A single missed month can permit larval maturation. • Sexual maturity: females typically have their first oestrus at 6–12 months; males become reproductively active from approximately 6–8 months. Manage intact dogs accordingly — unwanted pregnancies and the health risks of pyometra warrant a firm neutering timeline. • Neutering (if deferred from 6 months): most toy-breed protocols now recommend completion by 9–12 months. Laparoscopic ovariohysterectomy or ovariectomy is preferred for females when available — faster recovery, lower morbidity. • Behaviour: adolescent Cavaliers sometimes push boundaries but rarely become aggressive. Continued reward-based training, consistent routine, and adequate physical and mental enrichment (sniff walks, food puzzles, trick training) carry most through this stage. If separation anxiety persists or worsens, consult a veterinary behaviourist early rather than late. • Grooming establishment: by 12 months the adult silk coat is approaching full length. Establish a routine — full brush-through every 2–3 days (daily behind the ears and on feathering to prevent mats), ear inspection weekly, nail trim every 3–4 weeks, bath every 4–6 weeks. In tropical humidity, check ears after water exposure — the long, heavy ears trap moisture and create ideal conditions for otitis externa. • Nutrition transition: transition from puppy to adult food at 9–12 months. Choose a product formulated for adult small/toy breeds meeting AAFCO/FEDIAF maintenance standards. Cavaliers are prone to weight gain — measure food by weight, not volume. • First heartworm antigen test: at 12 months of age, perform a baseline heartworm antigen test even if the dog has been on prophylaxis — to confirm no infection established, and to set a baseline for ongoing annual testing.

The Cavalier reaches physical and social maturity in this window. This is the most critical period for breed-specific health screening — both for the dog's own welfare and, if breeding is contemplated, to uphold the protocols that alone can reduce the prevalence of MVD and CM/SM in future generations.

Breeding fitness — the MVD Breeding Protocol and CM/SM screening: If you are breeding your Cavalier, both parents must meet the CKCSC UK/USA MVD Breeding Protocol minimum requirements: (1) the dog is at least 2.5 years old, (2) has no murmur detected by a cardiologist at auscultation within the preceding 12 months, AND (3) both parents of the dog were free of murmur at age 2.5 years or older. Dogs not meeting all three criteria must not be bred. Additionally, the BVA/KC CM/SM scheme — or equivalent neurologist MRI assessment — is the gold standard for syringomyelia/Chiari screening before breeding.

• Annual cardiac auscultation from age 1: the CKCSC UK MVD Breeding Protocol requires annual heart auscultation by a veterinary cardiologist from age 1 year onward for dogs in a breeding programme. Pet dogs benefit equally — an early murmur detected at age 1–2 triggers more frequent monitoring and allows earlier initiation of evidence-based treatment (pimobendan in the preclinical phase, per the EPIC trial). • MVD Breeding Protocol compliance (minimum for breeding): dog must be ≥2.5 years old with a clear cardiac auscultation by a cardiologist AND have both parents certified clear at ≥2.5 years. Verify current criteria at cavalierhealth.org and the CKCSC UK. • CM/SM MRI screening (before breeding): the BVA/KC Chiari Malformation/Syringomyelia Scheme grades dogs by MRI findings. The gold standard is a neurologist-performed MRI at 2.5 years. Breeding from severely affected grades is strongly discouraged. Pet dogs showing neck pain, phantom scratching, or yelping should be assessed sooner, regardless of breeding status. • Episodic Falling Syndrome (EFS) DNA test: a DNA test for the causative BCAN gene variant is available; a single test is definitive for life. EFS-affected dogs suffer paroxysmal muscle hypertonicity triggered by excitement or exercise. Breeding stock should be genotyped; carriers can be bred to clear dogs with a managed programme. • Curly Coat/Dry Eye (CC/DE) DNA test: a DNA test for the FAM20A gene variant causing dry rough coat, absent tear film, and keratoconjunctivitis sicca is available. Test breeding stock; do not breed two carriers together. • Eye examination: annual ophthalmic examination by a BVA/KC-approved ophthalmologist (or equivalent) recommended for breeding dogs, screening for hereditary cataract, multifocal retinal dysplasia, and other KC-listed conditions. • Routine annual wellness exam: physical exam, weight and body condition score, full blood panel and urinalysis as baseline, dental assessment, parasite screen. • Dental: first professional dental scaling and polishing under general anaesthesia at 18–24 months if tartar accumulation warrants it. Anaesthetic-free dental cleaning is not equivalent and is not endorsed by WSAVA. • Nutrition: maintain adult feeding routine. Confirm body condition score is 4–5 on the 9-point scale at every vet visit. Lean weight demonstrably delays MVD progression in the Cavalier. • Enrichment: Cavaliers in this age bracket need approximately 45–60 minutes of moderate exercise daily, mental stimulation through scent work or food puzzles, and human companionship. They are companion dogs, not kennel dogs.

The majority of Cavaliers are physically healthy through the early-to-mid adult years, but this is the period during which the first cardiac murmur typically appears in a significant proportion of the population. Annual cardiac auscultation becomes not just prudent but essential from this point forward.

• Annual wellness exam: physical examination, body weight and body condition score, dental assessment, joint palpation. • Annual cardiac auscultation: by a veterinary cardiologist or an internist/general practitioner experienced in Cavalier cardiac disease. When a murmur is first detected, refer for echocardiography to stage the disease using ACVIM staging (Stage B1, B2, C, D). The EPIC trial (Boswood et al., 2016, JVIM) established that pimobendan started in Stage B2 (enlarged heart on echo, no clinical signs) significantly delays progression to congestive heart failure. • Echocardiography: recommended at least annually once a murmur is detected. In Stage B1 (murmur present, no cardiac enlargement), re-echo every 12 months. In Stage B2, echo every 6 months and commence pimobendan. • CM/SM monitoring: any new-onset neck pain, yelping without obvious cause, phantom scratching, altered gait, or head pressing warrants neurological assessment and MRI consideration, regardless of previous clear screens. • Dental prophylaxis: professional cleaning under anaesthesia as clinically indicated — typically every 1–2 years in a home with daily brushing, more frequently if brushing is irregular. Periodontal disease increases systemic inflammatory burden and has been associated with cardiac disease progression in dogs. • Parasite prevention: continue monthly heartworm prophylaxis and broad-spectrum antiparasitic cover without interruption. • Vaccination: core vaccines (CDV/CPV/CAV) every 3 years post the 12-month booster, per WSAVA guidelines. Leptospirosis and kennel cough annually. • Nutrition: if the dog is healthy and maintaining ideal body condition, no change to adult food is necessary. Some dogs benefit from a cardiac-supportive diet once in Stage B2 or beyond — discuss with a veterinary cardiologist or nutritionist. • Primary secretory otitis media (PSOM / "glue ear"): accumulation of mucus in the middle ear is a breed-specific condition that can be mistaken for hearing loss or vestibular disease; raise with your vet if the dog shakes its head persistently or seems to have reduced hearing. • Behaviour: any new-onset aggression, anxiety, or behaviour change in this age group has a medical differential (pain, neurological signs from SM) and warrants a veterinary workup before a purely behavioural approach.

By age 7, virtually all Cavaliers are in some stage of MVD monitoring. This stage brings a shift from annual to biannual veterinary visits, increased screening frequency for organ function, and the beginning of proactive quality-of-life planning. The transition is gradual — many Cavaliers at 7–8 years are still vigorous and active — but it calls for a more attentive clinical schedule.

• Biannual veterinary visits: at minimum every 6 months. This allows timely detection of cardiac progression, weight change, renal function decline (an important comorbidity in dogs on long-term cardiac medication), and new clinical signs. • Blood and urine monitoring: full biochemistry panel and urinalysis every 6–12 months. Dogs on furosemide and ACE inhibitors require electrolyte and renal function monitoring every 3–6 months. • Cardiac staging and management: many Cavaliers will progress to Stage B2 or Stage C (overt congestive heart failure, CHF) in this window. Stage C management typically involves furosemide, pimobendan, benazepril or enalapril, and spironolactone. The ACVIM 2019 Consensus Guidelines (Keene et al., JVIM 2019) provide the current evidence-based standard of care. • Exercise modification: dogs in Stage C CHF require restricted, gentle exercise (short lead walks, avoid heat and excitement). Dogs still in Stage B without CHF can continue normal moderate exercise. Do not preemptively restrict exercise in a dog with a murmur alone (Stage B1) — exercise capacity decline is a sign of progression, not a reason to anticipate restriction. • Nutrition — mature/senior transition: consider transitioning to a mature-adult food at age 7–8, particularly if the dog shows reduced activity, muscle loss, or weight gain. In dogs with CHF, sodium restriction may be appropriate — always based on cardiologist guidance. • Cognitive enrichment: continue daily mental stimulation. Maintaining mental engagement throughout maturity appears to be protective against cognitive dysfunction syndrome (CDS). • Dental: maintain annual professional scaling and polishing. In dogs on cardiac medication, anaesthetic risk must be assessed by the cardiologist and an experienced veterinary anaesthetist — safe anaesthetic protocols for Stage B2–C Cavaliers exist but require cardiac stabilisation and intra-operative monitoring. • Pain and mobility: arthritis is more common than the breed's small size might suggest. Weight management is the single most effective intervention. NSAIDs or alternatives (gabapentin, amantadine) may be appropriate — discuss before assuming any mild slowdown is simply old age. • Pet insurance review: review policy limits, excess, and co-payment structure. Monthly medication costs for a Cavalier in CHF (pimobendan alone can be substantial) are significant — know your coverage before costs escalate.

Cavaliers reaching 10 years have often lived with MVD for several years and may be in late-stage cardiac disease. The focus shifts from cure to quality of life, comfort, and the prevention of unnecessary suffering. This stage calls for frank, compassionate conversations with your vet about what constitutes a good life for your individual dog and how best to maintain it.

Median lifespan context: VetCompass data (McMillan et al., 2024) places the median Cavalier lifespan at approximately 10.45 years, with a small proportion reaching 14–15 years. Reaching 10 is an achievement that reflects good genetics, conscientious screening by the breeder, and attentive lifelong care. It is not the beginning of the end — many Cavaliers at 10 are still alert, engaged, and comfortable.

• Veterinary visits: every 3–6 months, or as directed by the cardiologist. Senior Cavaliers in Stage C–D cardiac disease may require more frequent monitoring during medication adjustments. • Stage D congestive heart failure (refractory CHF): Stage D represents CHF that fails to respond to standard therapy. Management options include dose escalation, addition of hydralazine as an arterial vasodilator adjunct, sildenafil for pulmonary hypertension, and advanced interventions. Quality of life, not survival at any cost, should guide decisions at this stage. • Palliative and supportive care: orthopaedic bedding (memory foam or similar), ramps instead of stairs, food and water at a raised but comfortable height, and avoidance of extremes of temperature and excitement are practical measures that improve daily quality of life. • Nutrition: caloric needs fall as activity decreases. Small, frequent, palatable meals are preferred for dogs with reduced appetite secondary to cardiac disease. Avoid high-sodium foods and treats. In cachexic cardiac dogs, maintaining caloric intake takes precedence over low-fat targets — discuss with your vet. • Medication compliance and owner support: owners managing a Cavalier in late CHF often administer 4–6 medications daily. Pill pockets, compounded palatable formulations, and a written schedule reduce errors. Carer fatigue is real — do not hesitate to ask your vet team for support. • Cognitive dysfunction syndrome (CDS): signs include night waking, disorientation, loss of house training, changed social behaviour, and altered sleep–wake cycles. Environmental modification (nightlights, consistent routine) and pharmacological support (selegiline, melatonin, dietary supplements) are supported by evidence. Distinguish CDS from pain, which can present similarly. • Neurological decline: SM-affected dogs may experience worsening pain and paresis in old age. Gabapentin, pregabalin, and omeprazole (CSF-pressure reduction) are the main palliative tools. Surgical decompression (foramen magnum decompression) is an option in younger dogs with severe SM; in a very old dog, surgical risk–benefit requires careful individual assessment. • Quality-of-life assessment: use a structured tool such as the HHHHHMM Scale (Hurt, Hunger, Hydration, Hygiene, Happiness, Mobility, More good days than bad) at every vet visit from age 10 onward. Document the dog's good days and bad days in writing — building a longitudinal record supports better-informed care discussions with your veterinarian.

Lifetime heartworm and parasite prevention: In tropical climates, Dirofilaria immitis transmission is year-round with no safe off-season. A monthly macrocyclic lactone (milbemycin, ivermectin, or moxidectin) given without gaps is the standard. Annual heartworm antigen testing confirms no infection has established. Tick prevention (isoxazoline class preferred for efficacy) is equally year-round. There is no age at which prevention can safely be discontinued — continue for the dog's lifetime.

• 2 weeks: first worming dose (pyrantel pamoate or fenbendazole). • 6–8 weeks: first puppy vaccination (DHPPi + Leptospirosis); heartworm prophylaxis and flea/tick prevention started. • 9–11 weeks: second puppy vaccination. • 12–16 weeks: third and final puppy vaccination (no earlier than 16 weeks). • 12–16 weeks: microchip implantation and dog licensing — confirm requirements with your local authority. • 6–12 months: EFS DNA test and CC/DE DNA test (if breeding is contemplated, or for owner information). • 9–12 months: neutering (timing guided by vet discussion). • 12 months: first annual booster (DHPPi + Leptospirosis + kennel cough); baseline heartworm antigen test; first cardiac auscultation by cardiologist for any dog in a breeding programme. • 12 months onward: annual cardiac auscultation for all Cavaliers. • 2.5 years: MVD Breeding Protocol assessment (cardiology auscultation, both-parent history confirmed); CM/SM neurologist MRI — gold-standard gate for breeding dogs. • 3–7 years: annual wellness exam; echocardiography as soon as a murmur is detected; continue annual cardiac auscultation. • 7 years onward: biannual vet visits; biannual bloods and urinalysis; echocardiography frequency per ACVIM staging. • 10 years onward: vet visits at least every 6 months; quality-of-life assessment at each visit; palliative care plan documented. • Lifelong: monthly heartworm prophylaxis and broad-spectrum antiparasitic without gaps; annual heartworm antigen test.

Temperamentally, yes — they are gentle, biddable and forgiving. The one thing a first-time owner must take seriously is sourcing from health-screened lines and budgeting for the breed's likely cardiac care.